InsiderTrades.com logo

ALNY Insider Trading

Insider Ownership Percentage: 1.20%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $94,865,117.67

Alnylam Pharmaceuticals Insider Trading History Chart

This chart shows the insider buying and selling history at Alnylam Pharmaceuticals by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Alnylam Pharmaceuticals Share Price & Price History

Current Price: $328.70
Price Change: ▲ Price Increase of +20.65 (6.70%)
As of 03/25/2026 05:00 PM ET

This chart shows the closing price history over time for ALNY up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Alnylam Pharmaceuticals Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/3/2026Kevin Joseph FitzgeraldEVPSell1,652$319.73$528,193.9621,860View SEC Filing Icon  
3/3/2026Pushkal GargEVPSell1,775$319.74$567,538.5023,406View SEC Filing Icon  
3/2/2026Jeffrey V. PoultonEVPSell2,206$327.65$722,795.9064,273View SEC Filing Icon  
3/2/2026Kevin Joseph FitzgeraldEVPSell1,598$327.65$523,584.7023,512View SEC Filing Icon  
3/2/2026Pushkal GargEVPSell1,717$327.66$562,592.2225,181View SEC Filing Icon  
3/2/2026Tolga TangulerEVPSell1,598$327.65$523,584.7036,606View SEC Filing Icon  
3/2/2026Yvonne GreenstreetCEOSell6,799$327.65$2,227,692.3598,628View SEC Filing Icon  
2/17/2026Kevin Joseph FitzgeraldEVPSell2,041$331.96$677,530.3621,264View SEC Filing Icon  
2/13/2026Jeffrey V. PoultonEVPSell2,242$310.08$695,199.3659,802View SEC Filing Icon  
2/13/2026Kevin Joseph FitzgeraldEVPSell1,959$310.08$607,446.7223,305View SEC Filing Icon  
2/13/2026Pushkal GargEVPSell2,242$310.08$695,199.3624,848View SEC Filing Icon  
2/13/2026Tolga TangulerEVPSell1,959$310.08$607,446.7231,769View SEC Filing Icon  
2/13/2026Yvonne GreenstreetCEOSell6,958$310.08$2,157,536.6485,662View SEC Filing Icon  
1/13/2026Kevin Joseph FitzgeraldEVPSell2,290$370.33$848,055.7021,264View SEC Filing Icon  
1/12/2026Jeffrey V. PoultonEVPSell2,780$362.87$1,008,778.6057,465View SEC Filing Icon  
1/12/2026Kevin Joseph FitzgeraldEVPSell1,510$362.87$547,933.7023,554View SEC Filing Icon  
1/12/2026Pushkal GargEVPSell1,510$362.87$547,933.7022,511View SEC Filing Icon  
1/12/2026Tolga TangulerEVPSell1,510$362.87$547,933.7029,728View SEC Filing Icon  
1/12/2026Yvonne GreenstreetCEOSell9,577$362.86$3,475,110.2278,411View SEC Filing Icon  
11/17/2025Kevin Joseph FitzgeraldEVPSell12,128$452.18$5,484,039.0421,264View SEC Filing Icon  
11/13/2025Yvonne GreenstreetCEOSell10,000$451.27$4,512,700.0065,409View SEC Filing Icon  
11/12/2025Yvonne GreenstreetCEOSell15,650$453.69$7,100,248.5065,409View SEC Filing Icon  
10/3/2025Pushkal GargEVPSell3,022$451.48$1,364,372.5620,221View SEC Filing Icon  
10/2/2025Jeffrey V. PoultonEVPSell3,821$452.05$1,727,283.0554,052View SEC Filing Icon  
10/2/2025Kevin Joseph FitzgeraldEVPSell2,441$452.05$1,103,454.0525,231View SEC Filing Icon  
10/2/2025Pushkal GargEVPSell2,937$452.05$1,327,670.8523,243View SEC Filing Icon  
10/2/2025Tolga TangulerEVPSell1,405$452.05$635,130.2527,438View SEC Filing Icon  
10/2/2025Yvonne GreenstreetCEOSell8,924$452.05$4,034,094.2065,409View SEC Filing Icon  
9/9/2025Colleen F. ReitanDirectorSell18,000$467.60$8,416,800.00775View SEC Filing Icon  
8/19/2025Pushkal GargEVPSell1,455$458.41$666,986.5520,221View SEC Filing Icon  
8/18/2025Jeffrey V. PoultonEVPSell2,274$453.27$1,030,735.9850,121View SEC Filing Icon  
8/18/2025Kevin Joseph FitzgeraldEVPSell1,396$453.27$632,764.9222,719View SEC Filing Icon  
8/18/2025Michael W. BonneyDirectorSell11,250$450.00$5,062,500.0016,804View SEC Filing Icon  
8/18/2025Pushkal GargEVPSell1,396$453.27$632,764.9221,676View SEC Filing Icon  
8/18/2025Tolga TangulerEVPSell1,396$453.27$632,764.9229,466View SEC Filing Icon  
8/18/2025Yvonne GreenstreetCEOSell6,979$453.27$3,163,371.3356,221View SEC Filing Icon  
8/14/2025Dennis A. AusielloDirectorSell31,448$436.58$13,729,567.84911View SEC Filing Icon  
6/2/2025Yvonne GreenstreetCEOSell19,297$306.00$5,904,882.0048,948View SEC Filing Icon  
5/30/2025Yvonne GreenstreetCEOSell31,640$304.39$9,630,899.6048,948View SEC Filing Icon  
2/18/2025Kevin Joseph FitzgeraldEVPSell1,440$251.56$362,246.4012,881View SEC Filing Icon  
2/18/2025Pushkal GargCMOSell1,548$251.67$389,585.1611,989View SEC Filing Icon  
2/14/2025Jeffrey V. PoultonCFOSell967$255.17$246,749.3932,786View SEC Filing Icon  
2/14/2025Kevin Joseph FitzgeraldEVPSell663$255.21$169,204.2314,321View SEC Filing Icon  
2/14/2025Pushkal GargCMOSell1,561$255.17$398,320.3713,537View SEC Filing Icon  
2/14/2025Yvonne GreenstreetCEOSell1,213$255.17$309,521.2181,526View SEC Filing Icon  
1/27/2025Pushkal GargCMOSell52,592$285.00$14,988,720.0011,989View SEC Filing Icon  
1/23/2025Phillip A. SharpDirectorSell11,250$275.00$3,093,750.00View SEC Filing Icon  
12/12/2024Pushkal GargCMOSell1,752$251.00$439,752.0015,705View SEC Filing Icon  
11/26/2024Pushkal GargCMOSell1,682$250.98$422,148.3617,457View SEC Filing Icon  
11/26/2024Tolga TangulerEVPSell1,469$250.98$368,689.6213,191View SEC Filing Icon  
11/26/2024Yvonne GreenstreetCEOSell5,219$250.98$1,309,864.6278,880View SEC Filing Icon  
8/20/2024Yvonne GreenstreetCEOSell15,000$280.00$4,200,000.0073,441View SEC Filing Icon  
8/6/2024Dennis A. AusielloDirectorSell20,250$262.00$5,305,500.00136View SEC Filing Icon  
8/1/2024Yvonne GreenstreetCEOSell15,148$270.00$4,089,960.0073,441View SEC Filing Icon  
7/11/2024Yvonne GreenstreetCEOSell7,093$261.00$1,851,273.0073,441View SEC Filing Icon  
6/25/2024Jeffrey V. PoultonCFOSell1,605$231.00$370,755.0028,892View SEC Filing Icon  
6/25/2024Kevin Joseph FitzgeraldEVPSell1,198$230.99$276,726.0214,181View SEC Filing Icon  
6/25/2024Pushkal GargCMOSell2,103$230.99$485,771.9715,609View SEC Filing Icon  
6/25/2024Yvonne GreenstreetCEOSell8,301$230.99$1,917,447.9980,534View SEC Filing Icon  
6/24/2024David E. I. PyottDirectorSell32,450$220.69$7,161,390.50136View SEC Filing Icon  
5/29/2024Amy W. SchulmanDirectorSell21,700$148.60$3,224,620.008,436View SEC Filing Icon  
12/27/2023Michael W. BonneyDirectorSell30,000$195.00$5,850,000.0016,029View SEC Filing Icon  
8/7/2023Pushkal GargCMOSell4,166$183.89$766,085.744,345View SEC Filing Icon  
8/4/2023Jeffrey V. PoultonCFOSell3,460$185.85$643,041.0015,873View SEC Filing Icon  
8/4/2023Pushkal GargCMOSell3,461$185.85$643,226.858,511View SEC Filing Icon  
8/4/2023Yvonne GreenstreetCEOSell4,057$185.85$753,993.4535,216View SEC Filing Icon  
4/27/2023Akshay VaishnawPresidentSell2,392$194.59$465,459.2817,890View SEC Filing Icon  
4/27/2023Jeffrey V. PoultonCFOSell977$194.59$190,114.4311,706View SEC Filing Icon  
4/27/2023Pushkal GargCMOSell1,839$194.59$357,851.016,800View SEC Filing Icon  
4/27/2023Tolga TangulerEVPSell1,476$194.59$287,214.841,801View SEC Filing Icon  
4/27/2023Yvonne GreenstreetCEOSell7,615$194.59$1,481,802.8530,332View SEC Filing Icon  
4/6/2023Indrani Lall FranchiniEVPSell3,500$210.00$735,000.00View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Alnylam Pharmaceuticals (NASDAQ:ALNY)

92.97% of Alnylam Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at ALNY by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Alnylam Pharmaceuticals Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
3/17/2026Rockefeller Capital Management L.P.8,124$3.23M0.0%+85.5%0.006%Search for SEC Filing on Google Icon
3/9/2026Corient Private Wealth LLC23,763$9.45M0.0%-39.7%0.018%Search for SEC Filing on Google Icon
3/6/2026Hsbc Holdings PLC89,517$35.68M0.0%+22.6%0.067%Search for SEC Filing on Google Icon
3/4/2026SHP Wealth Management109$43K0.0%N/A0.000%Search for SEC Filing on Google Icon
3/2/2026Reflection Asset Management159$63K0.0%N/A0.000%Search for SEC Filing on Google Icon
3/2/2026Wick Capital Partners LLC769$0.31M0.1%N/A0.001%Search for SEC Filing on Google Icon
2/27/2026Groupama Asset Managment35,878$14.27M0.2%-99.1%0.027%Search for SEC Filing on Google Icon
2/26/2026Alpine Global Management LLC2,062$0.82M0.1%N/A0.002%Search for SEC Filing on Google Icon
2/26/2026Anchor Investment Management LLC2,695$1.07M0.1%+19.8%0.002%Search for SEC Filing on Google Icon
2/25/2026MidFirst Bank541$0.22M0.0%N/A0.000%Search for SEC Filing on Google Icon
2/24/2026Pacer Advisors Inc.9,588$3.81M0.0%N/A0.007%Search for SEC Filing on Google Icon
2/23/2026Virtu Financial LLC2,941$1.17M0.0%-74.8%0.002%Search for SEC Filing on Google Icon
2/23/2026MV Capital Management Inc.63$25K0.0%N/A0.000%Search for SEC Filing on Google Icon
2/20/2026Kovitz Investment Group Partners LLC1,955$0.78M0.0%-25.0%0.001%Search for SEC Filing on Google Icon
2/19/2026T. Rowe Price Investment Management Inc.1,753,640$697.34M0.4%-19.3%1.322%Search for SEC Filing on Google Icon
2/19/2026Compound Planning Inc.907$0.36M0.0%-3.7%0.001%Search for SEC Filing on Google Icon
2/19/2026Corient Private Wealth LLC23,645$9.40M0.0%-40.0%0.018%Search for SEC Filing on Google Icon
2/18/2026Mercer Global Advisors Inc. ADV11,786$4.69M0.0%+2.6%0.009%Search for SEC Filing on Google Icon
2/18/2026Raymond James Financial Inc.388,705$154.43M0.0%+3.0%0.294%Search for SEC Filing on Google Icon
2/18/2026Vident Advisory LLC5,155$2.05M0.0%-1.6%0.004%Search for SEC Filing on Google Icon
2/18/2026Beacon Pointe Advisors LLC790$0.31M0.0%-17.2%0.001%Search for SEC Filing on Google Icon
2/18/2026EP Wealth Advisors LLC671$0.27M0.0%N/A0.001%Search for SEC Filing on Google Icon
2/18/2026Mackenzie Financial Corp12,395$4.91M0.0%+26.8%0.009%Search for SEC Filing on Google Icon
2/18/2026Coastal Bridge Advisors LLC1,048$0.42M0.0%-4.5%0.001%Search for SEC Filing on Google Icon
2/18/2026Empowered Funds LLC19,431$7.73M0.1%+353.5%0.015%Search for SEC Filing on Google Icon
2/18/2026XTX Topco Ltd1,856$0.74M0.0%+122.5%0.001%Search for SEC Filing on Google Icon
2/18/2026Zacks Investment Management12,008$4.78M0.0%+0.9%0.009%Search for SEC Filing on Google Icon
2/18/2026Zurich Insurance Group Ltd FI30,322$12.06M0.1%+1.1%0.023%Search for SEC Filing on Google Icon
2/18/2026Utah Retirement Systems20,725$8.24M0.1%+0.6%0.016%Search for SEC Filing on Google Icon
2/18/2026Voloridge Investment Management LLC160,577$63.85M0.2%-55.0%0.122%Search for SEC Filing on Google Icon
2/18/2026Virtus Investment Advisers LLC1,717$0.68M0.2%+17.7%0.001%Search for SEC Filing on Google Icon
2/18/2026Wellington Management Group LLP1,628,931$647.74M0.2%-62.4%1.233%Search for SEC Filing on Google Icon
2/18/2026SummitTX Capital L.P.3,465$1.38M0.0%-54.0%0.003%Search for SEC Filing on Google Icon
2/18/2026Toronto Dominion Bank23,199$9.23M0.0%+9.3%0.018%Search for SEC Filing on Google Icon
2/18/2026Summit Securities Group LLC202$80K0.0%N/A0.000%Search for SEC Filing on Google Icon
2/18/2026Polymer Capital Management US LLC3,070$1.22M0.1%+280.0%0.002%Search for SEC Filing on Google Icon
2/18/2026Orbimed Advisors LLC288,800$114.84M2.4%-4.2%0.219%Search for SEC Filing on Google Icon
2/18/2026Oxford Asset Management LLP2,534$1.01M0.4%-24.4%0.002%Search for SEC Filing on Google Icon
2/18/2026Man Group plc144,210$57.35M0.1%+101.2%0.109%Search for SEC Filing on Google Icon
2/18/2026Hunting Hill Global Capital LLC4,259$1.69M1.2%N/A0.003%Search for SEC Filing on Google Icon
2/18/2026Investment Management Corp of Ontario21,535$8.56M0.1%-43.3%0.016%Search for SEC Filing on Google Icon
2/18/2026Janus Henderson Group PLC136,425$54.25M0.0%+0.4%0.103%Search for SEC Filing on Google Icon
2/18/2026Gotham Asset Management LLC39,622$15.76M0.1%+40.8%0.030%Search for SEC Filing on Google Icon
2/18/2026Evolve Private Wealth LLC1,783$0.71M0.0%N/A0.001%Search for SEC Filing on Google Icon
2/18/2026Engineers Gate Manager LP20,199$8.03M0.1%-53.9%0.015%Search for SEC Filing on Google Icon
2/18/2026Casdin Capital LLC75,000$29.82M1.9%+36.4%0.057%Search for SEC Filing on Google Icon
2/18/2026Artia Global Partners LP17,400$6.92M1.0%-49.7%0.013%Search for SEC Filing on Google Icon
2/18/2026Banco Bilbao Vizcaya Argentaria S.A.21,926$8.72M0.1%-1.4%0.017%Search for SEC Filing on Google Icon
2/18/2026Bridgeway Capital Management LLC5,990$2.38M0.0%-0.7%0.005%Search for SEC Filing on Google Icon
2/18/2026Align Financial LLC198,825$7.91M0.0%N/A0.150%Search for SEC Filing on Google Icon
2/17/2026Guggenheim Capital LLC40,135$15.96M0.1%+365.3%0.030%Search for SEC Filing on Google Icon
2/17/2026Caisse de depot et placement du Quebec51,598$20.52M0.0%+189.5%0.039%Search for SEC Filing on Google Icon
2/17/2026Schonfeld Strategic Advisors LLC44,894$17.85M0.1%+362.4%0.034%Search for SEC Filing on Google Icon
2/17/2026AQR Capital Management LLC919,959$365.82M0.2%+23.6%0.694%Search for SEC Filing on Google Icon
2/17/2026Abel Hall LLC1,111$0.44M0.1%N/A0.001%Search for SEC Filing on Google Icon
2/17/2026EFG International AG26,400$10.50M0.2%N/A0.020%Search for SEC Filing on Google Icon
2/17/2026Cetera Investment Advisers17,549$6.98M0.0%+20.8%0.013%Search for SEC Filing on Google Icon
2/17/2026Lazard Asset Management LLC10,152$4.04M0.0%-99.0%0.008%Search for SEC Filing on Google Icon
2/17/2026Hilltop Holdings Inc.1,139$0.45M0.0%-4.2%0.001%Search for SEC Filing on Google Icon
2/17/2026Laird Norton Wetherby Trust Company LLC3,501$1.39M0.0%N/A0.003%Search for SEC Filing on Google Icon
2/17/2026Trexquant Investment LP26,741$10.63M0.1%+115.7%0.020%Search for SEC Filing on Google Icon
2/17/2026FIL Ltd94,164$37.44M0.0%-30.5%0.071%Search for SEC Filing on Google Icon
2/17/2026Orbis Allan Gray Ltd1,618,219$643.49M2.7%-17.1%1.220%Search for SEC Filing on Google Icon
2/17/2026Jump Financial LLC30,562$12.15M0.1%-12.4%0.023%Search for SEC Filing on Google Icon
2/17/2026Northern Trust Corp857,742$341.08M0.0%+3.0%0.647%Search for SEC Filing on Google Icon
2/17/2026Vinva Investment Management Ltd17,961$7.14M0.1%+1,327.7%0.014%Search for SEC Filing on Google Icon
2/17/2026Price T Rowe Associates Inc. MD1,702,831$677.13M0.1%-5.4%1.284%Search for SEC Filing on Google Icon
2/17/2026T. Rowe Price Investment Management Inc.1,151,347$457.83M0.5%-47.0%0.868%Search for SEC Filing on Google Icon
2/17/2026Rock Springs Capital Management LP71,250$28.33M1.5%-4.0%0.054%Search for SEC Filing on Google Icon
2/17/2026Quantitative Investment Management LLC4,331$1.72M0.2%N/A0.003%Search for SEC Filing on Google Icon
2/17/2026Osaic Holdings Inc.44,718$17.78M0.0%+79.3%0.034%Search for SEC Filing on Google Icon
2/17/2026Advisory Services Network LLC8,093$3.22M0.0%+15.5%0.006%Search for SEC Filing on Google Icon
2/17/2026Himension Capital Singapore PTE. LTD.10,185$4.05M0.2%+0.9%0.008%Search for SEC Filing on Google Icon
2/17/2026Tower Research Capital LLC TRC 5,841$2.32M0.1%+280.0%0.004%Search for SEC Filing on Google Icon
2/17/2026Public Employees Retirement System of Ohio44,498$17.70M0.1%+14.1%0.034%Search for SEC Filing on Google Icon
2/17/2026California State Teachers Retirement System201,816$80.25M0.1%-1.0%0.152%Search for SEC Filing on Google Icon
2/17/2026Diadema Partners LP5,341$2.12M0.4%-46.6%0.004%Search for SEC Filing on Google Icon
2/17/2026Russell Investments Group Ltd.165,740$65.90M0.1%-23.2%0.125%Search for SEC Filing on Google Icon
2/17/2026Maryland State Retirement & Pension System6,346$2.52M0.1%+2.6%0.005%Search for SEC Filing on Google Icon
2/17/2026Captrust Financial Advisors13,255$5.27M0.0%+72.8%0.010%Search for SEC Filing on Google Icon
2/17/2026&PARTNERS2,697$1.07M0.0%-1.7%0.002%Search for SEC Filing on Google Icon
2/17/2026Blair William & Co. IL9,774$3.89M0.0%-4.6%0.007%Search for SEC Filing on Google Icon
2/17/2026Titan Wealth CI Ltd105$42K0.0%N/A0.000%Search for SEC Filing on Google Icon
2/17/2026Graham Capital Management L.P.588$0.23M0.0%-80.5%0.000%Search for SEC Filing on Google Icon
2/17/2026Royal Bank of Canada591,495$235.21M0.0%+35.4%0.446%Search for SEC Filing on Google Icon
2/17/2026Persistent Asset Partners Ltd1,433$0.57M0.3%-36.4%0.001%Search for SEC Filing on Google Icon
2/17/2026Polar Capital Holdings Plc240,606$95.68M0.4%-4.3%0.181%Search for SEC Filing on Google Icon
2/17/2026Rothschild Wealth LLC1,051$0.42M0.0%N/A0.001%Search for SEC Filing on Google Icon
2/17/2026Oddo BHF Asset Management Sas30,133$11.98M0.4%-20.6%0.023%Search for SEC Filing on Google Icon
2/17/2026Rakuten Investment Management Inc.12,684$5.06M0.0%-59.3%0.010%Search for SEC Filing on Google Icon
2/17/2026L2 Asset Management LLC671$0.27M0.0%+9.8%0.001%Search for SEC Filing on Google Icon
2/17/2026Cynosure Group LLC950$0.38M0.0%N/A0.001%Search for SEC Filing on Google Icon
2/17/2026Faithward Advisors LLC3,774$1.50M0.2%N/A0.003%Search for SEC Filing on Google Icon
2/16/2026Silvant Capital Management LLC17,964$7.14M0.2%+1.6%0.014%Search for SEC Filing on Google Icon
2/16/2026USS Investment Management Ltd26,224$10.43M0.1%-0.5%0.020%Search for SEC Filing on Google Icon
2/16/2026Vanguard Personalized Indexing Management LLC13,727$5.46M0.1%-1.8%0.010%Search for SEC Filing on Google Icon
2/16/2026Verition Fund Management LLC4,005$1.59M0.0%-76.5%0.003%Search for SEC Filing on Google Icon
2/16/2026Panagora Asset Management Inc.30,843$12.27M0.0%-50.5%0.023%Search for SEC Filing on Google Icon
2/16/2026Mariner LLC42,443$16.88M0.0%+61.2%0.032%Search for SEC Filing on Google Icon
2/16/2026Focus Partners Wealth7,083$2.82M0.0%+7.0%0.005%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Alnylam Pharmaceuticals logo
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. Its marketed products include ONPATTRO (patisiran) for the treatment of the polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; AMVUTTRA for the treatment of hATTR amyloidosis with polyneuropathy in adults; GIVLAARI for the treatment of adults with acute hepatic porphyria; and OXLUMO for the treatment of primary hyperoxaluria type 1. In addition, the company develops patisiran for the treatment of transthyretin amyloidosis, or ATTR amyloidosis, with cardiomyopathy; cemdisiran to treat complement-mediated diseases; Belcesiran for the treatment of alpha-1 liver disease; Elebsiran to treat chronic HBV infection; Zilebesiran to treat hypertension; ALN-APP to treat Alzheimer's disease and cerebral amyloid angiopathy; and ALN-HSD to treat NASH. Further, it offers Fitusiran for the treatment of hemophilia, Inclisiran to treat hypercholesterolemia, lumasiran for the treatment of advanced PH1, and vutrisiran for the treatment of ATTR amyloidosis, which is in phase 3 clinical trial. Alnylam Pharmaceuticals, Inc. has strategic collaborations with Regeneron Pharmaceuticals, Inc. to discover, develop, and commercialize RNAi therapeutics for a range of diseases by addressing therapeutic targets expressed in the eye and CNS; and Roche to develop pharmaceutical products containing zilebesiran. It also has license and collaboration agreements with Novartis AG; Vir Biotechnology, Inc.; Dicerna Pharmaceuticals, Inc.; Ionis Pharmaceuticals, Inc.; and PeptiDream, Inc. The company was founded in 2002 and is headquartered in Cambridge, Massachusetts.
Read More on Alnylam Pharmaceuticals

Today's Range

Now: $328.70
Low: $311.71
High: $329.48

50 Day Range

MA: $332.89
Low: $306.66
High: $370.00

52 Week Range

Now: $328.70
Low: $205.87
High: $495.55

Volume

1,139,637 shs

Average Volume

1,413,195 shs

Market Capitalization

$43.59 billion

P/E Ratio

192.22

Dividend Yield

N/A

Beta

0.36

Who are the company insiders with the largest holdings of Alnylam Pharmaceuticals?

Alnylam Pharmaceuticals' top insider investors include:
  1. Yvonne Greenstreet (CEO)
  2. Jeffrey V Poulton (EVP)
  3. Tolga Tanguler (EVP)
  4. Jeffrey V Poulton (CFO)
  5. Kevin Joseph Fitzgerald (EVP)
  6. Pushkal Garg (EVP)
  7. Pushkal Garg (CMO)
  8. Michael W Bonney (Director)
  9. Amy W Schulman (Director)
  10. Dennis A Ausiello (Director)
  11. Colleen F Reitan (Director)
  12. David E I Pyott (Director)
  13. Phillip A Sharp (Director)
Learn More about top insider investors at Alnylam Pharmaceuticals.

Who are the major institutional investors of Alnylam Pharmaceuticals?

Alnylam Pharmaceuticals' top institutional shareholders include:
  1. Capital World Investors — 12.34%
  2. Vanguard Group Inc. — 10.26%
  3. Capital Research Global Investors — 5.13%
  4. Geode Capital Management LLC — 2.01%
  5. Baillie Gifford & Co. — 1.97%
  6. Norges Bank — 1.71%
Learn More about top institutional investors of Alnylam Pharmaceuticals stock.

Which major investors are selling Alnylam Pharmaceuticals stock?

In the last quarter, ALNY stock was sold by these institutional investors:
  1. Groupama Asset Managment
  2. Macquarie Group Ltd.
  3. Wellington Management Group LLP
  4. Gabelli Funds LLC
  5. T. Rowe Price Investment Management Inc.
  6. Lazard Asset Management LLC
  7. Bank of New York Mellon Corp
  8. Capital Research Global Investors
During the last year, company insiders that have sold Alnylam Pharmaceuticals company stock include:
  1. Yvonne Greenstreet (CEO)
  2. Jeffrey V Poulton (EVP)
  3. Tolga Tanguler (EVP)
  4. Jeffrey V Poulton (CFO)
  5. Kevin Joseph Fitzgerald (EVP)
  6. Pushkal Garg (EVP)
  7. Pushkal Garg (CMO)
  8. Michael W Bonney (Director)
Learn More investors selling Alnylam Pharmaceuticals stock.

Which major investors are buying Alnylam Pharmaceuticals stock?

In the previous quarter, ALNY stock was acquired by institutional investors including:
  1. Norges Bank
  2. FengHe Fund Management Pte. Ltd.
  3. ProShare Advisors LLC
  4. Hudson Bay Capital Management LP
  5. Align Financial LLC
  6. AQR Capital Management LLC
  7. Royal Bank of Canada
  8. Geode Capital Management LLC

Alnylam Pharmaceuticals Active Insiders

Jeffrey W Dunn
CEO
John Maraganore
John Maraganore (Age 63)
CEO
Yvonne Greenstreet
Yvonne Greenstreet (Age 63)
COO
6 recent trades
Jeffrey V Poulton
Jeffrey V Poulton (Age 58)
CFO
4 recent trades
Phillip A Sharp
Phillip A Sharp
Director
Steven M Paul
Steven M Paul
Director
Michael W Bonney
Director
Amy W Schulman
Amy W Schulman
Director
David E I Pyott
Director
Dennis A Ausiello
Dennis A Ausiello
Director
Colleen F Reitan
Colleen F Reitan
Director
Laurie Keating
Laurie Keating (Age 72)
EVP
Tolga Tanguler
Tolga Tanguler
EVP
4 recent trades
Indrani Lall Franchini
Indrani Lall Franchini (Age 54)
EVP
Kevin Joseph Fitzgerald
Kevin Joseph Fitzgerald
EVP
8 recent trades
Akshay Vaishnaw
Akshay Vaishnaw (Age 63)
Insider
Pushkal Garg
Pushkal Garg (Age 58)
CMO
6 recent trades